Postpartum hemorrhage (PPH) contributes substantially to maternal morbidity and mortality globally. First–line treatment includes uterotonics, uterine massage, and fluid resuscitation. Uterine balloon tamponade is recommended for uterine atony refractory to first-line treatment. International guidelines limit the context of tamponade use to settings where surgical intervention and blood products are readily available, not accounting for disparities in access to such resources at birthing centers. Further evaluation of PPH tamponade devices for utilization in multiple care settings is needed. We conducted a feasibility study of uterine tamponade devices among midwifery and medical students.